GR3000993T3 - Renin inhibitors and methods for using same - Google Patents
Renin inhibitors and methods for using sameInfo
- Publication number
- GR3000993T3 GR3000993T3 GR90400832T GR900400832T GR3000993T3 GR 3000993 T3 GR3000993 T3 GR 3000993T3 GR 90400832 T GR90400832 T GR 90400832T GR 900400832 T GR900400832 T GR 900400832T GR 3000993 T3 GR3000993 T3 GR 3000993T3
- Authority
- GR
- Greece
- Prior art keywords
- methods
- same
- renin inhibitors
- renin
- rise
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/553—Renin inhibitors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/86—Renin inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/795,282 US4906613A (en) | 1985-11-05 | 1985-11-05 | Antiglaucoma compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3000993T3 true GR3000993T3 (en) | 1991-12-10 |
Family
ID=25165170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR90400832T GR3000993T3 (en) | 1985-11-05 | 1990-10-29 | Renin inhibitors and methods for using same |
Country Status (8)
Country | Link |
---|---|
US (2) | US4906613A (el) |
EP (2) | EP0243477A1 (el) |
JP (1) | JPS63501287A (el) |
AT (1) | ATE55054T1 (el) |
DE (1) | DE3673161D1 (el) |
ES (1) | ES2031822T3 (el) |
GR (1) | GR3000993T3 (el) |
WO (1) | WO1987002581A1 (el) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4927807A (en) * | 1987-10-06 | 1990-05-22 | Abbott Laboratories | Glaucoma treatment |
US5036051A (en) * | 1987-10-06 | 1991-07-30 | Abbott Laboratories | Glaucoma treatment |
US5346887A (en) * | 1987-10-06 | 1994-09-13 | Abbott Laboratories | Glaucoma treatment |
GB8728561D0 (en) * | 1987-12-07 | 1988-01-13 | Glaxo Group Ltd | Chemical compounds |
GB8728560D0 (en) * | 1987-12-07 | 1988-01-13 | Glaxo Group Ltd | Chemical compounds |
EP0326364B1 (en) * | 1988-01-26 | 1994-06-22 | Sankyo Company Limited | Renin inhibitory oligopeptides, their preparation and use |
US5059589A (en) * | 1988-09-08 | 1991-10-22 | Abbott Laboratories | Glaucoma treatment |
US5268374A (en) * | 1988-10-04 | 1993-12-07 | Abbott Laboratories | Non-peptide renin inhibitors |
IL92011A0 (en) * | 1988-10-19 | 1990-07-12 | Abbott Lab | Heterocyclic peptide renin inhibitors |
US5164388A (en) * | 1988-10-19 | 1992-11-17 | Abbott Laboratories | Heterocyclic peptide renin inhibitors |
EP0449943A1 (en) * | 1988-12-22 | 1991-10-09 | The Upjohn Company | Transdermal and intranasal administration of renin inhibitory peptides |
FR2647675B1 (fr) * | 1989-06-05 | 1994-05-20 | Sanofi | Utilisation d'un derive de la statine dans le traitement des affections oculaires |
US5063208A (en) * | 1989-07-26 | 1991-11-05 | Abbott Laboratories | Peptidyl aminodiol renin inhibitors |
US5688770A (en) * | 1989-12-14 | 1997-11-18 | Schering Corporation | Antiglaucoma compositions and methods |
US5182266A (en) * | 1990-01-31 | 1993-01-26 | Abbott Laboratories | Method for treating renal disease |
IE911326A1 (en) * | 1990-04-23 | 1991-10-23 | Abbott Lab | Psoriasis treatment |
IE68045B1 (en) * | 1990-05-11 | 1996-05-15 | Abbott Lab | Renin inhibitors |
US5332742A (en) * | 1990-05-11 | 1994-07-26 | Abbott Laboratories | Renin inhibitors |
JPH04243835A (ja) * | 1990-08-29 | 1992-08-31 | Pfizer Inc | 高眼圧症又は緑内障治療用薬剤組成物及び治療方法 |
GB9127041D0 (en) * | 1991-12-20 | 1992-02-19 | Fujisawa Pharmaceutical Co | New use |
US6165490A (en) * | 1996-04-05 | 2000-12-26 | Staar Surgical Ag | Biological material, method of preparing such materials, uses thereof and products made therefrom |
US8889112B2 (en) * | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
US20020082288A1 (en) * | 1999-09-16 | 2002-06-27 | Gerald Horn | Ophthalmic formulations comprising an imidazoline |
WO2001019364A1 (en) | 1999-09-16 | 2001-03-22 | Horn Gerald D | A method for optimizing pupil size using alpha antagonist |
US6730065B1 (en) | 2000-09-15 | 2004-05-04 | Ocularis Pharma, Inc. | Night vision composition |
US6420407B1 (en) | 1999-09-16 | 2002-07-16 | Gerald Horn | Ophthalmic formulation which modulates dilation |
US20060211753A1 (en) * | 2000-11-03 | 2006-09-21 | Ocularis Pharma, Inc. | Method and composition which reduces stimulation of muscles which dilate the eye |
KR20080021782A (ko) | 2005-06-17 | 2008-03-07 | 리지너크스 바이오 파마소티컬스, 인코포레이티드 | 엘케이케이티이티 및/또는 엘케이케이티엔티 펩티드조성물들 및 그 방법 |
PT2950648T (pt) | 2013-02-01 | 2020-01-06 | Ocuphire Pharma Inc | Soluções oftálmicas aquosas de fentolamina e usos médicos |
WO2014121028A1 (en) | 2013-02-01 | 2014-08-07 | Ocularis Pharma, Llc | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance |
KR20210096096A (ko) | 2018-10-26 | 2021-08-04 | 오큐파이어 파마, 인크. | 노안, 산동, 및 기타 안구 장애의 치료를 위한 방법 및 조성물 |
CA3168400A1 (en) | 2020-02-19 | 2021-08-26 | Vestlandets Innovasjonsselskap As | Treatment of corneal vascularisation |
CN115368310A (zh) | 2021-05-18 | 2022-11-22 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985875A (en) * | 1974-01-12 | 1976-10-12 | Dainippon Pharmaceutical Co., Ltd. | ω-(N-acylamino)alkylphosphoryl ethanolamines, pharmaceutical compositions containing them, and their uses |
FR2399409A1 (fr) * | 1977-08-04 | 1979-03-02 | Anvar | Nouveaux derives de la pepstatine, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4269827A (en) * | 1980-06-23 | 1981-05-26 | The Massachusetts General Hospital | Process and composition for reducing blood pressure |
NO812612L (no) * | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
US4384994A (en) * | 1981-10-08 | 1983-05-24 | Merck & Co., Inc. | Renin inhibitory peptides |
US4478826A (en) * | 1981-10-08 | 1984-10-23 | Merck & Co., Inc. | Renin inhibitory peptides |
US4470971A (en) * | 1981-10-19 | 1984-09-11 | Merck & Co., Inc. | Renin inhibitory peptides having His13 |
US4479941A (en) * | 1981-12-10 | 1984-10-30 | Merck & Co., Inc. | Renin inhibitory peptides having PHE13 delection |
FR2531951A1 (fr) * | 1982-08-17 | 1984-02-24 | Sanofi Sa | Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent |
US4478827A (en) * | 1983-05-09 | 1984-10-23 | The General Hospital Corporation | Renin inhibitors |
US4455303A (en) * | 1983-05-24 | 1984-06-19 | The General Hospital Corporation | Renin inhibitors |
US4485099A (en) * | 1983-06-15 | 1984-11-27 | Merck & Co., Inc. | Renin inhibitors containing a C-terminal amide cycle |
US4477440A (en) * | 1983-09-14 | 1984-10-16 | Merck & Co., Inc. | Renin inhibitors containing an n-terminal disulfide cycle |
US4477441A (en) * | 1983-09-14 | 1984-10-16 | Merck & Co., Inc. | Renin inhibitors containing a C-terminal disulfide cycle |
US4602093A (en) * | 1984-02-08 | 1986-07-22 | Merck & Co., Inc. | Novel substituted imidazoles, their preparation and use |
US4510085A (en) * | 1984-04-12 | 1985-04-09 | G.D. Searle & Co. | Antihypertensive tetrapeptide amides |
US4514332A (en) * | 1984-04-16 | 1985-04-30 | G. D. Searle & Co. | Tetrapeptide adamantyl amides |
US4574127A (en) * | 1984-05-07 | 1986-03-04 | Merck & Co., Inc. | Oxazoles and thiazoles containing an aminohydroxypropoxyphenyl moiety |
US4749698A (en) * | 1985-07-08 | 1988-06-07 | Rorer Pharmaceutical Corporation | Antihypertensive derivatives |
-
1985
- 1985-11-05 US US06/795,282 patent/US4906613A/en not_active Expired - Fee Related
-
1986
- 1986-10-31 DE DE8686308492T patent/DE3673161D1/de not_active Expired - Fee Related
- 1986-10-31 EP EP86906688A patent/EP0243477A1/en active Pending
- 1986-10-31 ES ES198686308492T patent/ES2031822T3/es not_active Expired - Lifetime
- 1986-10-31 JP JP61503365A patent/JPS63501287A/ja active Pending
- 1986-10-31 EP EP86308492A patent/EP0246381B1/en not_active Expired - Lifetime
- 1986-10-31 WO PCT/US1986/002291 patent/WO1987002581A1/en not_active Application Discontinuation
- 1986-10-31 AT AT86308492T patent/ATE55054T1/de not_active IP Right Cessation
-
1989
- 1989-12-14 US US07/450,766 patent/US5352666A/en not_active Expired - Fee Related
-
1990
- 1990-10-29 GR GR90400832T patent/GR3000993T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1987002581A1 (en) | 1987-05-07 |
EP0243477A1 (en) | 1987-11-04 |
ES2031822T3 (es) | 1993-01-01 |
ATE55054T1 (de) | 1990-08-15 |
EP0246381B1 (en) | 1990-08-01 |
US4906613A (en) | 1990-03-06 |
US5352666A (en) | 1994-10-04 |
JPS63501287A (ja) | 1988-05-19 |
EP0246381A1 (en) | 1987-11-25 |
DE3673161D1 (de) | 1990-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3000993T3 (en) | Renin inhibitors and methods for using same | |
AU4135289A (en) | Pharmaceutically active combination | |
AU553408B2 (en) | Laser to place indicia on precious stone | |
GB2204606B (en) | Bandages and a method for the application of tubular bandages | |
AU4019289A (en) | Hiv protease inhibitors useful for the treatment of aids | |
AU1310395A (en) | A device for the supply of oxygen and/or other gases to a patient | |
AU6128886A (en) | Method for the treatment of a gas mixture by adsorpton | |
EP0206517A3 (en) | A method of controlling fuel supply and a fuel injection apparatus | |
ES8704730A1 (es) | Procedimiento para preparar un medicamento a base de 2-amino-3-carboctaxiamino-6-(4-fluoro-bencilamino) piridina y un espasmolitico. | |
AU6772387A (en) | Treatment of thrombosis with fibrinolytic agents and prostacyclines | |
SE8803085L (sv) | Dosform foer avgivande av diltiazem | |
AU5485186A (en) | Methods and apparatus for sanitary steam injection | |
AU4670789A (en) | Castanospermine esters in the inhibition of tumor metastasis | |
EP0328957A3 (en) | Mixture of a thrombolytically acting and an antithrombolytically acting substance | |
ZA891439B (en) | 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion | |
AU583370B2 (en) | Annular nozzle and process for its use | |
AU4090589A (en) | The use of plasminogen activator inhibitor (pai-2) for immunosuppression | |
AU547196B2 (en) | Substitued derivatives of phenoxyalkanoic acids and cyclohexanedione | |
AU2143488A (en) | Use of a compound for the treatment of sleep disorders and depression | |
EP0192037A3 (en) | Shut-off device, especially for high-pressure fluids, and use of the device | |
AU575357B2 (en) | Acetylene derivatives and treatment of hypertension | |
CA2105888A1 (fr) | Utilisation d'un inhibiteur direct de la thrombine pour la fabrication d'un medicament a activite thrombolytique | |
HUT52541A (en) | Process for increasing of the molecule-mass of hydrocarbon and/or its derivatives | |
ZA866810B (en) | A pharmaceutical composition for the treatment of high blood pressure | |
AU552897B2 (en) | 3 acyl thiazolidine carboxylic acids |